# Gilead Sciences Inc. (GILD) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $10.02B |
| 2024 | $1.66B |
| 2023 | $7.61B |
| 2022 | $7.33B |
| 2021 | $9.92B |
| 2020 | $4.07B |
| 2019 | $4.29B |
| 2018 | $8.20B |
| 2017 | $14.12B |
| 2016 | $17.63B |
| 2015 | $22.19B |
| 2014 | $15.27B |
| 2013 | $4.52B |
| 2012 | $4.01B |
| 2011 | $3.79B |
| 2010 | $3.96B |
| 2009 | $3.53B |
| 2008 | $2.68B |
| 2007 | $2.16B |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $2.59B |
| 2025-09-30 | $3.33B |
| 2025-06-30 | $2.47B |
| 2025-03-31 | $2.24B |
| 2024-09-30 | $888M |
| 2024-06-30 | $2.64B |
| 2024-03-31 | -$4.32B |
| 2023-09-30 | $2.62B |
| 2023-06-30 | $1.67B |
| 2023-03-31 | $1.71B |
| 2022-09-30 | $2.84B |
| 2022-06-30 | $2.03B |
| 2022-03-31 | $197M |
| 2021-09-30 | $3.84B |
| 2021-06-30 | $2.25B |
| 2021-03-31 | $2.89B |
| 2020-09-30 | $2.00B |
| 2020-06-30 | -$2.98B |
| 2020-03-31 | $2.40B |
| 2019-09-30 | -$1.47B |
| 2019-06-30 | $2.43B |
| 2019-03-31 | $2.24B |
| 2018-09-30 | $2.62B |
| 2018-06-30 | $2.28B |

Source: [MarketCapTrends](https://marketcaptrends.com/company/GILD/operating-income)